Cargando...

A Revolution in Treatment for Hepatitis C Infection: Mitigating the Budgetary Impact

In a Perspective accompanying Hill and colleagues, Elliot Marseille and James Kahn compare the history of pricing and availability of ART for HIV with that of the new HCV drugs and discuss strategies for providing treatment in LMIC even in the face of high costs.

Gardado en:
Detalles Bibliográficos
Publicado en:PLoS Med
Main Authors: Marseille, Elliot, Kahn, James G.
Formato: Artigo
Idioma:Inglês
Publicado: Public Library of Science 2016
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4886960/
https://ncbi.nlm.nih.gov/pubmed/27243461
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pmed.1002031
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!